Press Releases

Date Title and Summary View
Toggle Summary Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome
VANCOUVER, British Columbia , June 27, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), today announced that the Phase 3 LEADERSHIP 301 clinical trial evaluating once-daily, oral rosiptor (AQX-1125) for the treatment of interstitial cystitis/bladder pain syndrome
View HTML
Toggle Summary Aquinox Pharmaceuticals Announces Initiation of ProShip Phase 2 Proof-of-Concept Clinical Trial Investigating Rosiptor in CP/CPPS
- Trial Will Enroll Approximately 100 Male Subjects in the US and Canada - VANCOUVER, British Columbia , June 11, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat
View HTML
Toggle Summary Aquinox to Present at 2018 UBS Global Healthcare Conference
VANCOUVER, British Columbia , May 16, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (“ Aquinox ”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, announced today that David
View HTML
Toggle Summary Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
-Aquinox to Receive $25M in Upfront Payment, Potentially Over $100M in Additional Milestone Payments and Royalties- -Astellas to Obtain Development and Commercialization Rights to Rosiptor, Aquinox’s Lead Drug Candidate, in Japan and Certain Other Countries in the Asia-Pacific Region- VANCOUVER,
View HTML
Toggle Summary Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results
VANCOUVER, British Columbia , May 08, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, today provided a corporate
View HTML
Toggle Summary Aquinox Pharmaceuticals Announces Year End 2017 Financial Results
VANCOUVER, British Columbia , March 12, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, today provided a
View HTML
Toggle Summary Aquinox Pharmaceuticals to Announce Year End 2017 Financial Results
Conference call Monday March 12, 2018 at 4:30 PM ET VANCOUVER, British Columbia , March 05, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation,
View HTML
Toggle Summary Aquinox Provides Enrollment Update for LEADERSHIP 301 Clinical Trial of Rosiptor
--Enrollment target reached; topline data  on track for Q3 2018 announcement-- NEW YORK , Feb. 09, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation,
View HTML
Toggle Summary Aquinox to Present at LEERINK Partners 7th Annual Global Healthcare Conference
VANCOUVER, British Columbia , Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (“ Aquinox ”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, today announced that
View HTML
Toggle Summary Aquinox to Host Analyst and Investor Event in New York City
External Expert, Management to Present on IC/BPS and Clinical Development Program VANCOUVER, British Columbia , Jan. 26, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to
View HTML